Vanguard Capital Management
VNDA icon

Vanguard Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Vanguard Capital Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.4M Buy
2,524,040
+42,549
+2% +$278K ﹤0.01% 2583
2026
Q1 		$17.1M Buy
+2,481,491
New +$19.1M ﹤0.01% 2435

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management's VNDA Position: Q2 2026 in Review

Vanguard Capital Management increased its Vanda Pharmaceuticals (VNDA) stake by 1.7% in Q2 2026, buying an estimated $278K and bringing the position to 2,524,040 shares worth $15.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2583.

Vanguard Capital Management first reported a position in VNDA in Q1 2026 and has held it in 2 quarters since. The position peaked at $17.1M in Q1 2026. 171 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Vanguard Capital Management held 2,524,040 shares of Vanda Pharmaceuticals worth $15.4M as of Q2 2026.
  • Vanguard Capital Management bought 42,549 Vanda Pharmaceuticals shares in Q2 2026, an estimated $278K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2583 holding.
  • Vanguard Capital Management first reported a position in Vanda Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's Vanda Pharmaceuticals position peaked at $17.1M in Q1 2026.
  • 171 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.